...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: New blog entry: Disrupting Treatment of Cardiovascular Disease with Epigenetics

Hi rm2.

I really like the clear communications style this time - focuses on the end benefits and emphasizes the progress they have made.

The "RVX is not for sale" I've always interpreted as meaning not for sale at the prices and deal structure that BP would offer at this time. My guess is that Eastern and NGN want to take big gains on this stock and that could happen via other investors as RVX becomes an operating company with strong revenue.

Hepalink could be a big part of this equation as they have the inside scoop particularly with their part of BETonMACE phalli.

Cheers

Toinv

Share
New Message
Please login to post a reply